Medical Care
Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Research Report 2025
- May 12, 25
- ID: 236268
- Pages: 87
- Figures: 87
- Views: 35
The global market for Antibody Drug Conjugate Linker And Conjugation Technologies was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antibody Drug Conjugate Linker And Conjugation Technologies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody Drug Conjugate Linker And Conjugation Technologies.
The Antibody Drug Conjugate Linker And Conjugation Technologies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antibody Drug Conjugate Linker And Conjugation Technologies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibody Drug Conjugate Linker And Conjugation Technologies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Seattle Genetics Inc
Immunogen
Ambrx
Catalent Biologics
Immunomedics
Mersana Therapeutics
Sutro Biopharma
Iksuda Therapeutics
Legochem Biosciences
Linxis
Adc Therapeutics
Segment by Type
Chemical Conjugation
Enzymatic Conjugation
Segment by Application
Leukemia
Lymphoma
Breast Cancer
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibody Drug Conjugate Linker And Conjugation Technologies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antibody Drug Conjugate Linker And Conjugation Technologies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody Drug Conjugate Linker And Conjugation Technologies.
The Antibody Drug Conjugate Linker And Conjugation Technologies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antibody Drug Conjugate Linker And Conjugation Technologies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibody Drug Conjugate Linker And Conjugation Technologies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Seattle Genetics Inc
Immunogen
Ambrx
Catalent Biologics
Immunomedics
Mersana Therapeutics
Sutro Biopharma
Iksuda Therapeutics
Legochem Biosciences
Linxis
Adc Therapeutics
Segment by Type
Chemical Conjugation
Enzymatic Conjugation
Segment by Application
Leukemia
Lymphoma
Breast Cancer
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibody Drug Conjugate Linker And Conjugation Technologies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Chemical Conjugation
1.2.3 Enzymatic Conjugation
1.3 Market by Application
1.3.1 Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Leukemia
1.3.3 Lymphoma
1.3.4 Breast Cancer
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Perspective (2020-2031)
2.2 Global Antibody Drug Conjugate Linker And Conjugation Technologies Growth Trends by Region
2.2.1 Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Antibody Drug Conjugate Linker And Conjugation Technologies Historic Market Size by Region (2020-2025)
2.2.3 Antibody Drug Conjugate Linker And Conjugation Technologies Forecasted Market Size by Region (2026-2031)
2.3 Antibody Drug Conjugate Linker And Conjugation Technologies Market Dynamics
2.3.1 Antibody Drug Conjugate Linker And Conjugation Technologies Industry Trends
2.3.2 Antibody Drug Conjugate Linker And Conjugation Technologies Market Drivers
2.3.3 Antibody Drug Conjugate Linker And Conjugation Technologies Market Challenges
2.3.4 Antibody Drug Conjugate Linker And Conjugation Technologies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antibody Drug Conjugate Linker And Conjugation Technologies Players by Revenue
3.1.1 Global Top Antibody Drug Conjugate Linker And Conjugation Technologies Players by Revenue (2020-2025)
3.1.2 Global Antibody Drug Conjugate Linker And Conjugation Technologies Revenue Market Share by Players (2020-2025)
3.2 Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Antibody Drug Conjugate Linker And Conjugation Technologies Revenue
3.4 Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Concentration Ratio
3.4.1 Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antibody Drug Conjugate Linker And Conjugation Technologies Revenue in 2024
3.5 Global Key Players of Antibody Drug Conjugate Linker And Conjugation Technologies Head office and Area Served
3.6 Global Key Players of Antibody Drug Conjugate Linker And Conjugation Technologies, Product and Application
3.7 Global Key Players of Antibody Drug Conjugate Linker And Conjugation Technologies, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antibody Drug Conjugate Linker And Conjugation Technologies Breakdown Data by Type
4.1 Global Antibody Drug Conjugate Linker And Conjugation Technologies Historic Market Size by Type (2020-2025)
4.2 Global Antibody Drug Conjugate Linker And Conjugation Technologies Forecasted Market Size by Type (2026-2031)
5 Antibody Drug Conjugate Linker And Conjugation Technologies Breakdown Data by Application
5.1 Global Antibody Drug Conjugate Linker And Conjugation Technologies Historic Market Size by Application (2020-2025)
5.2 Global Antibody Drug Conjugate Linker And Conjugation Technologies Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size (2020-2031)
6.2 North America Antibody Drug Conjugate Linker And Conjugation Technologies Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2020-2025)
6.4 North America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antibody Drug Conjugate Linker And Conjugation Technologies Market Size (2020-2031)
7.2 Europe Antibody Drug Conjugate Linker And Conjugation Technologies Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2020-2025)
7.4 Europe Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antibody Drug Conjugate Linker And Conjugation Technologies Market Size (2020-2031)
8.2 Asia-Pacific Antibody Drug Conjugate Linker And Conjugation Technologies Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Region (2020-2025)
8.4 Asia-Pacific Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size (2020-2031)
9.2 Latin America Antibody Drug Conjugate Linker And Conjugation Technologies Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2020-2025)
9.4 Latin America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antibody Drug Conjugate Linker And Conjugation Technologies Market Size (2020-2031)
10.2 Middle East & Africa Antibody Drug Conjugate Linker And Conjugation Technologies Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2020-2025)
10.4 Middle East & Africa Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Seattle Genetics Inc
11.1.1 Seattle Genetics Inc Company Details
11.1.2 Seattle Genetics Inc Business Overview
11.1.3 Seattle Genetics Inc Antibody Drug Conjugate Linker And Conjugation Technologies Introduction
11.1.4 Seattle Genetics Inc Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
11.1.5 Seattle Genetics Inc Recent Development
11.2 Immunogen
11.2.1 Immunogen Company Details
11.2.2 Immunogen Business Overview
11.2.3 Immunogen Antibody Drug Conjugate Linker And Conjugation Technologies Introduction
11.2.4 Immunogen Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
11.2.5 Immunogen Recent Development
11.3 Ambrx
11.3.1 Ambrx Company Details
11.3.2 Ambrx Business Overview
11.3.3 Ambrx Antibody Drug Conjugate Linker And Conjugation Technologies Introduction
11.3.4 Ambrx Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
11.3.5 Ambrx Recent Development
11.4 Catalent Biologics
11.4.1 Catalent Biologics Company Details
11.4.2 Catalent Biologics Business Overview
11.4.3 Catalent Biologics Antibody Drug Conjugate Linker And Conjugation Technologies Introduction
11.4.4 Catalent Biologics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
11.4.5 Catalent Biologics Recent Development
11.5 Immunomedics
11.5.1 Immunomedics Company Details
11.5.2 Immunomedics Business Overview
11.5.3 Immunomedics Antibody Drug Conjugate Linker And Conjugation Technologies Introduction
11.5.4 Immunomedics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
11.5.5 Immunomedics Recent Development
11.6 Mersana Therapeutics
11.6.1 Mersana Therapeutics Company Details
11.6.2 Mersana Therapeutics Business Overview
11.6.3 Mersana Therapeutics Antibody Drug Conjugate Linker And Conjugation Technologies Introduction
11.6.4 Mersana Therapeutics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
11.6.5 Mersana Therapeutics Recent Development
11.7 Sutro Biopharma
11.7.1 Sutro Biopharma Company Details
11.7.2 Sutro Biopharma Business Overview
11.7.3 Sutro Biopharma Antibody Drug Conjugate Linker And Conjugation Technologies Introduction
11.7.4 Sutro Biopharma Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
11.7.5 Sutro Biopharma Recent Development
11.8 Iksuda Therapeutics
11.8.1 Iksuda Therapeutics Company Details
11.8.2 Iksuda Therapeutics Business Overview
11.8.3 Iksuda Therapeutics Antibody Drug Conjugate Linker And Conjugation Technologies Introduction
11.8.4 Iksuda Therapeutics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
11.8.5 Iksuda Therapeutics Recent Development
11.9 Legochem Biosciences
11.9.1 Legochem Biosciences Company Details
11.9.2 Legochem Biosciences Business Overview
11.9.3 Legochem Biosciences Antibody Drug Conjugate Linker And Conjugation Technologies Introduction
11.9.4 Legochem Biosciences Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
11.9.5 Legochem Biosciences Recent Development
11.10 Linxis
11.10.1 Linxis Company Details
11.10.2 Linxis Business Overview
11.10.3 Linxis Antibody Drug Conjugate Linker And Conjugation Technologies Introduction
11.10.4 Linxis Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
11.10.5 Linxis Recent Development
11.11 Adc Therapeutics
11.11.1 Adc Therapeutics Company Details
11.11.2 Adc Therapeutics Business Overview
11.11.3 Adc Therapeutics Antibody Drug Conjugate Linker And Conjugation Technologies Introduction
11.11.4 Adc Therapeutics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
11.11.5 Adc Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Chemical Conjugation
1.2.3 Enzymatic Conjugation
1.3 Market by Application
1.3.1 Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Leukemia
1.3.3 Lymphoma
1.3.4 Breast Cancer
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Perspective (2020-2031)
2.2 Global Antibody Drug Conjugate Linker And Conjugation Technologies Growth Trends by Region
2.2.1 Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Antibody Drug Conjugate Linker And Conjugation Technologies Historic Market Size by Region (2020-2025)
2.2.3 Antibody Drug Conjugate Linker And Conjugation Technologies Forecasted Market Size by Region (2026-2031)
2.3 Antibody Drug Conjugate Linker And Conjugation Technologies Market Dynamics
2.3.1 Antibody Drug Conjugate Linker And Conjugation Technologies Industry Trends
2.3.2 Antibody Drug Conjugate Linker And Conjugation Technologies Market Drivers
2.3.3 Antibody Drug Conjugate Linker And Conjugation Technologies Market Challenges
2.3.4 Antibody Drug Conjugate Linker And Conjugation Technologies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antibody Drug Conjugate Linker And Conjugation Technologies Players by Revenue
3.1.1 Global Top Antibody Drug Conjugate Linker And Conjugation Technologies Players by Revenue (2020-2025)
3.1.2 Global Antibody Drug Conjugate Linker And Conjugation Technologies Revenue Market Share by Players (2020-2025)
3.2 Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Antibody Drug Conjugate Linker And Conjugation Technologies Revenue
3.4 Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Concentration Ratio
3.4.1 Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antibody Drug Conjugate Linker And Conjugation Technologies Revenue in 2024
3.5 Global Key Players of Antibody Drug Conjugate Linker And Conjugation Technologies Head office and Area Served
3.6 Global Key Players of Antibody Drug Conjugate Linker And Conjugation Technologies, Product and Application
3.7 Global Key Players of Antibody Drug Conjugate Linker And Conjugation Technologies, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antibody Drug Conjugate Linker And Conjugation Technologies Breakdown Data by Type
4.1 Global Antibody Drug Conjugate Linker And Conjugation Technologies Historic Market Size by Type (2020-2025)
4.2 Global Antibody Drug Conjugate Linker And Conjugation Technologies Forecasted Market Size by Type (2026-2031)
5 Antibody Drug Conjugate Linker And Conjugation Technologies Breakdown Data by Application
5.1 Global Antibody Drug Conjugate Linker And Conjugation Technologies Historic Market Size by Application (2020-2025)
5.2 Global Antibody Drug Conjugate Linker And Conjugation Technologies Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size (2020-2031)
6.2 North America Antibody Drug Conjugate Linker And Conjugation Technologies Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2020-2025)
6.4 North America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antibody Drug Conjugate Linker And Conjugation Technologies Market Size (2020-2031)
7.2 Europe Antibody Drug Conjugate Linker And Conjugation Technologies Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2020-2025)
7.4 Europe Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antibody Drug Conjugate Linker And Conjugation Technologies Market Size (2020-2031)
8.2 Asia-Pacific Antibody Drug Conjugate Linker And Conjugation Technologies Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Region (2020-2025)
8.4 Asia-Pacific Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size (2020-2031)
9.2 Latin America Antibody Drug Conjugate Linker And Conjugation Technologies Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2020-2025)
9.4 Latin America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antibody Drug Conjugate Linker And Conjugation Technologies Market Size (2020-2031)
10.2 Middle East & Africa Antibody Drug Conjugate Linker And Conjugation Technologies Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2020-2025)
10.4 Middle East & Africa Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Seattle Genetics Inc
11.1.1 Seattle Genetics Inc Company Details
11.1.2 Seattle Genetics Inc Business Overview
11.1.3 Seattle Genetics Inc Antibody Drug Conjugate Linker And Conjugation Technologies Introduction
11.1.4 Seattle Genetics Inc Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
11.1.5 Seattle Genetics Inc Recent Development
11.2 Immunogen
11.2.1 Immunogen Company Details
11.2.2 Immunogen Business Overview
11.2.3 Immunogen Antibody Drug Conjugate Linker And Conjugation Technologies Introduction
11.2.4 Immunogen Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
11.2.5 Immunogen Recent Development
11.3 Ambrx
11.3.1 Ambrx Company Details
11.3.2 Ambrx Business Overview
11.3.3 Ambrx Antibody Drug Conjugate Linker And Conjugation Technologies Introduction
11.3.4 Ambrx Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
11.3.5 Ambrx Recent Development
11.4 Catalent Biologics
11.4.1 Catalent Biologics Company Details
11.4.2 Catalent Biologics Business Overview
11.4.3 Catalent Biologics Antibody Drug Conjugate Linker And Conjugation Technologies Introduction
11.4.4 Catalent Biologics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
11.4.5 Catalent Biologics Recent Development
11.5 Immunomedics
11.5.1 Immunomedics Company Details
11.5.2 Immunomedics Business Overview
11.5.3 Immunomedics Antibody Drug Conjugate Linker And Conjugation Technologies Introduction
11.5.4 Immunomedics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
11.5.5 Immunomedics Recent Development
11.6 Mersana Therapeutics
11.6.1 Mersana Therapeutics Company Details
11.6.2 Mersana Therapeutics Business Overview
11.6.3 Mersana Therapeutics Antibody Drug Conjugate Linker And Conjugation Technologies Introduction
11.6.4 Mersana Therapeutics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
11.6.5 Mersana Therapeutics Recent Development
11.7 Sutro Biopharma
11.7.1 Sutro Biopharma Company Details
11.7.2 Sutro Biopharma Business Overview
11.7.3 Sutro Biopharma Antibody Drug Conjugate Linker And Conjugation Technologies Introduction
11.7.4 Sutro Biopharma Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
11.7.5 Sutro Biopharma Recent Development
11.8 Iksuda Therapeutics
11.8.1 Iksuda Therapeutics Company Details
11.8.2 Iksuda Therapeutics Business Overview
11.8.3 Iksuda Therapeutics Antibody Drug Conjugate Linker And Conjugation Technologies Introduction
11.8.4 Iksuda Therapeutics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
11.8.5 Iksuda Therapeutics Recent Development
11.9 Legochem Biosciences
11.9.1 Legochem Biosciences Company Details
11.9.2 Legochem Biosciences Business Overview
11.9.3 Legochem Biosciences Antibody Drug Conjugate Linker And Conjugation Technologies Introduction
11.9.4 Legochem Biosciences Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
11.9.5 Legochem Biosciences Recent Development
11.10 Linxis
11.10.1 Linxis Company Details
11.10.2 Linxis Business Overview
11.10.3 Linxis Antibody Drug Conjugate Linker And Conjugation Technologies Introduction
11.10.4 Linxis Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
11.10.5 Linxis Recent Development
11.11 Adc Therapeutics
11.11.1 Adc Therapeutics Company Details
11.11.2 Adc Therapeutics Business Overview
11.11.3 Adc Therapeutics Antibody Drug Conjugate Linker And Conjugation Technologies Introduction
11.11.4 Adc Therapeutics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
11.11.5 Adc Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Chemical Conjugation
Table 3. Key Players of Enzymatic Conjugation
Table 4. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Region (2020-2025)
Table 8. Global Antibody Drug Conjugate Linker And Conjugation Technologies Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Region (2026-2031)
Table 10. Antibody Drug Conjugate Linker And Conjugation Technologies Market Trends
Table 11. Antibody Drug Conjugate Linker And Conjugation Technologies Market Drivers
Table 12. Antibody Drug Conjugate Linker And Conjugation Technologies Market Challenges
Table 13. Antibody Drug Conjugate Linker And Conjugation Technologies Market Restraints
Table 14. Global Antibody Drug Conjugate Linker And Conjugation Technologies Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Players (2020-2025)
Table 16. Global Top Antibody Drug Conjugate Linker And Conjugation Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies as of 2024)
Table 17. Ranking of Global Top Antibody Drug Conjugate Linker And Conjugation Technologies Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Antibody Drug Conjugate Linker And Conjugation Technologies Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Antibody Drug Conjugate Linker And Conjugation Technologies, Headquarters and Area Served
Table 20. Global Key Players of Antibody Drug Conjugate Linker And Conjugation Technologies, Product and Application
Table 21. Global Key Players of Antibody Drug Conjugate Linker And Conjugation Technologies, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Antibody Drug Conjugate Linker And Conjugation Technologies Revenue Market Share by Type (2020-2025)
Table 25. Global Antibody Drug Conjugate Linker And Conjugation Technologies Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Antibody Drug Conjugate Linker And Conjugation Technologies Revenue Market Share by Type (2026-2031)
Table 27. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Antibody Drug Conjugate Linker And Conjugation Technologies Revenue Market Share by Application (2020-2025)
Table 29. Global Antibody Drug Conjugate Linker And Conjugation Technologies Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Antibody Drug Conjugate Linker And Conjugation Technologies Revenue Market Share by Application (2026-2031)
Table 31. North America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Antibody Drug Conjugate Linker And Conjugation Technologies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Antibody Drug Conjugate Linker And Conjugation Technologies Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Antibody Drug Conjugate Linker And Conjugation Technologies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2026-2031) & (US$ Million)
Table 46. Seattle Genetics Inc Company Details
Table 47. Seattle Genetics Inc Business Overview
Table 48. Seattle Genetics Inc Antibody Drug Conjugate Linker And Conjugation Technologies Product
Table 49. Seattle Genetics Inc Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025) & (US$ Million)
Table 50. Seattle Genetics Inc Recent Development
Table 51. Immunogen Company Details
Table 52. Immunogen Business Overview
Table 53. Immunogen Antibody Drug Conjugate Linker And Conjugation Technologies Product
Table 54. Immunogen Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025) & (US$ Million)
Table 55. Immunogen Recent Development
Table 56. Ambrx Company Details
Table 57. Ambrx Business Overview
Table 58. Ambrx Antibody Drug Conjugate Linker And Conjugation Technologies Product
Table 59. Ambrx Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025) & (US$ Million)
Table 60. Ambrx Recent Development
Table 61. Catalent Biologics Company Details
Table 62. Catalent Biologics Business Overview
Table 63. Catalent Biologics Antibody Drug Conjugate Linker And Conjugation Technologies Product
Table 64. Catalent Biologics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025) & (US$ Million)
Table 65. Catalent Biologics Recent Development
Table 66. Immunomedics Company Details
Table 67. Immunomedics Business Overview
Table 68. Immunomedics Antibody Drug Conjugate Linker And Conjugation Technologies Product
Table 69. Immunomedics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025) & (US$ Million)
Table 70. Immunomedics Recent Development
Table 71. Mersana Therapeutics Company Details
Table 72. Mersana Therapeutics Business Overview
Table 73. Mersana Therapeutics Antibody Drug Conjugate Linker And Conjugation Technologies Product
Table 74. Mersana Therapeutics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025) & (US$ Million)
Table 75. Mersana Therapeutics Recent Development
Table 76. Sutro Biopharma Company Details
Table 77. Sutro Biopharma Business Overview
Table 78. Sutro Biopharma Antibody Drug Conjugate Linker And Conjugation Technologies Product
Table 79. Sutro Biopharma Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025) & (US$ Million)
Table 80. Sutro Biopharma Recent Development
Table 81. Iksuda Therapeutics Company Details
Table 82. Iksuda Therapeutics Business Overview
Table 83. Iksuda Therapeutics Antibody Drug Conjugate Linker And Conjugation Technologies Product
Table 84. Iksuda Therapeutics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025) & (US$ Million)
Table 85. Iksuda Therapeutics Recent Development
Table 86. Legochem Biosciences Company Details
Table 87. Legochem Biosciences Business Overview
Table 88. Legochem Biosciences Antibody Drug Conjugate Linker And Conjugation Technologies Product
Table 89. Legochem Biosciences Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025) & (US$ Million)
Table 90. Legochem Biosciences Recent Development
Table 91. Linxis Company Details
Table 92. Linxis Business Overview
Table 93. Linxis Antibody Drug Conjugate Linker And Conjugation Technologies Product
Table 94. Linxis Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025) & (US$ Million)
Table 95. Linxis Recent Development
Table 96. Adc Therapeutics Company Details
Table 97. Adc Therapeutics Business Overview
Table 98. Adc Therapeutics Antibody Drug Conjugate Linker And Conjugation Technologies Product
Table 99. Adc Therapeutics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025) & (US$ Million)
Table 100. Adc Therapeutics Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
Table 104. Authors List of This Report
List of Figures
Figure 1. Antibody Drug Conjugate Linker And Conjugation Technologies Picture
Figure 2. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Type: 2024 VS 2031
Figure 4. Chemical Conjugation Features
Figure 5. Enzymatic Conjugation Features
Figure 6. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Application: 2024 VS 2031
Figure 8. Leukemia Case Studies
Figure 9. Lymphoma Case Studies
Figure 10. Breast Cancer Case Studies
Figure 11. Others Case Studies
Figure 12. Antibody Drug Conjugate Linker And Conjugation Technologies Report Years Considered
Figure 13. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Region: 2024 VS 2031
Figure 16. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Players in 2024
Figure 17. Global Top Antibody Drug Conjugate Linker And Conjugation Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Antibody Drug Conjugate Linker And Conjugation Technologies Revenue in 2024
Figure 19. North America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Country (2020-2031)
Figure 21. United States Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Country (2020-2031)
Figure 25. Germany Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Region (2020-2031)
Figure 33. China Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Country (2020-2031)
Figure 41. Mexico Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Country (2020-2031)
Figure 45. Turkey Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Seattle Genetics Inc Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
Figure 49. Immunogen Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
Figure 50. Ambrx Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
Figure 51. Catalent Biologics Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
Figure 52. Immunomedics Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
Figure 53. Mersana Therapeutics Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
Figure 54. Sutro Biopharma Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
Figure 55. Iksuda Therapeutics Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
Figure 56. Legochem Biosciences Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
Figure 57. Linxis Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
Figure 58. Adc Therapeutics Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Chemical Conjugation
Table 3. Key Players of Enzymatic Conjugation
Table 4. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Region (2020-2025)
Table 8. Global Antibody Drug Conjugate Linker And Conjugation Technologies Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Region (2026-2031)
Table 10. Antibody Drug Conjugate Linker And Conjugation Technologies Market Trends
Table 11. Antibody Drug Conjugate Linker And Conjugation Technologies Market Drivers
Table 12. Antibody Drug Conjugate Linker And Conjugation Technologies Market Challenges
Table 13. Antibody Drug Conjugate Linker And Conjugation Technologies Market Restraints
Table 14. Global Antibody Drug Conjugate Linker And Conjugation Technologies Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Players (2020-2025)
Table 16. Global Top Antibody Drug Conjugate Linker And Conjugation Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies as of 2024)
Table 17. Ranking of Global Top Antibody Drug Conjugate Linker And Conjugation Technologies Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Antibody Drug Conjugate Linker And Conjugation Technologies Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Antibody Drug Conjugate Linker And Conjugation Technologies, Headquarters and Area Served
Table 20. Global Key Players of Antibody Drug Conjugate Linker And Conjugation Technologies, Product and Application
Table 21. Global Key Players of Antibody Drug Conjugate Linker And Conjugation Technologies, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Antibody Drug Conjugate Linker And Conjugation Technologies Revenue Market Share by Type (2020-2025)
Table 25. Global Antibody Drug Conjugate Linker And Conjugation Technologies Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Antibody Drug Conjugate Linker And Conjugation Technologies Revenue Market Share by Type (2026-2031)
Table 27. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Antibody Drug Conjugate Linker And Conjugation Technologies Revenue Market Share by Application (2020-2025)
Table 29. Global Antibody Drug Conjugate Linker And Conjugation Technologies Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Antibody Drug Conjugate Linker And Conjugation Technologies Revenue Market Share by Application (2026-2031)
Table 31. North America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Antibody Drug Conjugate Linker And Conjugation Technologies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Antibody Drug Conjugate Linker And Conjugation Technologies Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Antibody Drug Conjugate Linker And Conjugation Technologies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2026-2031) & (US$ Million)
Table 46. Seattle Genetics Inc Company Details
Table 47. Seattle Genetics Inc Business Overview
Table 48. Seattle Genetics Inc Antibody Drug Conjugate Linker And Conjugation Technologies Product
Table 49. Seattle Genetics Inc Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025) & (US$ Million)
Table 50. Seattle Genetics Inc Recent Development
Table 51. Immunogen Company Details
Table 52. Immunogen Business Overview
Table 53. Immunogen Antibody Drug Conjugate Linker And Conjugation Technologies Product
Table 54. Immunogen Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025) & (US$ Million)
Table 55. Immunogen Recent Development
Table 56. Ambrx Company Details
Table 57. Ambrx Business Overview
Table 58. Ambrx Antibody Drug Conjugate Linker And Conjugation Technologies Product
Table 59. Ambrx Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025) & (US$ Million)
Table 60. Ambrx Recent Development
Table 61. Catalent Biologics Company Details
Table 62. Catalent Biologics Business Overview
Table 63. Catalent Biologics Antibody Drug Conjugate Linker And Conjugation Technologies Product
Table 64. Catalent Biologics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025) & (US$ Million)
Table 65. Catalent Biologics Recent Development
Table 66. Immunomedics Company Details
Table 67. Immunomedics Business Overview
Table 68. Immunomedics Antibody Drug Conjugate Linker And Conjugation Technologies Product
Table 69. Immunomedics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025) & (US$ Million)
Table 70. Immunomedics Recent Development
Table 71. Mersana Therapeutics Company Details
Table 72. Mersana Therapeutics Business Overview
Table 73. Mersana Therapeutics Antibody Drug Conjugate Linker And Conjugation Technologies Product
Table 74. Mersana Therapeutics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025) & (US$ Million)
Table 75. Mersana Therapeutics Recent Development
Table 76. Sutro Biopharma Company Details
Table 77. Sutro Biopharma Business Overview
Table 78. Sutro Biopharma Antibody Drug Conjugate Linker And Conjugation Technologies Product
Table 79. Sutro Biopharma Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025) & (US$ Million)
Table 80. Sutro Biopharma Recent Development
Table 81. Iksuda Therapeutics Company Details
Table 82. Iksuda Therapeutics Business Overview
Table 83. Iksuda Therapeutics Antibody Drug Conjugate Linker And Conjugation Technologies Product
Table 84. Iksuda Therapeutics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025) & (US$ Million)
Table 85. Iksuda Therapeutics Recent Development
Table 86. Legochem Biosciences Company Details
Table 87. Legochem Biosciences Business Overview
Table 88. Legochem Biosciences Antibody Drug Conjugate Linker And Conjugation Technologies Product
Table 89. Legochem Biosciences Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025) & (US$ Million)
Table 90. Legochem Biosciences Recent Development
Table 91. Linxis Company Details
Table 92. Linxis Business Overview
Table 93. Linxis Antibody Drug Conjugate Linker And Conjugation Technologies Product
Table 94. Linxis Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025) & (US$ Million)
Table 95. Linxis Recent Development
Table 96. Adc Therapeutics Company Details
Table 97. Adc Therapeutics Business Overview
Table 98. Adc Therapeutics Antibody Drug Conjugate Linker And Conjugation Technologies Product
Table 99. Adc Therapeutics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025) & (US$ Million)
Table 100. Adc Therapeutics Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
Table 104. Authors List of This Report
List of Figures
Figure 1. Antibody Drug Conjugate Linker And Conjugation Technologies Picture
Figure 2. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Type: 2024 VS 2031
Figure 4. Chemical Conjugation Features
Figure 5. Enzymatic Conjugation Features
Figure 6. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Application: 2024 VS 2031
Figure 8. Leukemia Case Studies
Figure 9. Lymphoma Case Studies
Figure 10. Breast Cancer Case Studies
Figure 11. Others Case Studies
Figure 12. Antibody Drug Conjugate Linker And Conjugation Technologies Report Years Considered
Figure 13. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Region: 2024 VS 2031
Figure 16. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Players in 2024
Figure 17. Global Top Antibody Drug Conjugate Linker And Conjugation Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Antibody Drug Conjugate Linker And Conjugation Technologies Revenue in 2024
Figure 19. North America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Country (2020-2031)
Figure 21. United States Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Country (2020-2031)
Figure 25. Germany Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Region (2020-2031)
Figure 33. China Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Country (2020-2031)
Figure 41. Mexico Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Country (2020-2031)
Figure 45. Turkey Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Seattle Genetics Inc Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
Figure 49. Immunogen Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
Figure 50. Ambrx Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
Figure 51. Catalent Biologics Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
Figure 52. Immunomedics Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
Figure 53. Mersana Therapeutics Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
Figure 54. Sutro Biopharma Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
Figure 55. Iksuda Therapeutics Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
Figure 56. Legochem Biosciences Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
Figure 57. Linxis Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
Figure 58. Adc Therapeutics Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232